Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro
Authors
Keywords
-
Journal
Frontiers in Molecular Neuroscience
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-09
DOI
10.3389/fnmol.2017.00441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The science and ethics of cell-based therapies for Parkinson's disease
- (2017) C.R. Towns PARKINSONISM & RELATED DISORDERS
- Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7
- (2017) Enrico Raffaele Fantoni et al. EJNMMI Research
- The Protective Effects of Icariin against the Homocysteine-Induced Neurotoxicity in the Primary Embryonic Cultures of Rat Cortical Neurons
- (2016) Xiao-Ang Li et al. MOLECULES
- Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats
- (2016) Shilei Song et al. PATHOLOGY RESEARCH AND PRACTICE
- The impact of 1MeTIQ on the dopaminergic system function in the 6-OHDA model of Parkinson’s disease
- (2016) Agnieszka Wąsik et al. Pharmacological Reports
- Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway
- (2016) Haroon Badshah et al. Scientific Reports
- Disrupted brain metabolic connectivity in a 6-OHDA-induced mouse model of Parkinson’s disease examined using persistent homology-based analysis
- (2016) Hyung-Jun Im et al. Scientific Reports
- Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation
- (2015) B. Liu et al. NEUROSCIENCE
- AnIn VivoMicrodialysis Study of FLZ Penetration through the Blood-Brain Barrier in Normal and 6-Hydroxydopamine Induced Parkinson’s Disease Model Rats
- (2014) Jinfeng Hou et al. Biomed Research International
- Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial Overactivation
- (2011) Xiaoming Hu et al. Journal of Neuroimmune Pharmacology
- HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration
- (2011) H.-M. Gao et al. JOURNAL OF NEUROSCIENCE
- Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: Behavioral, neurochemical and immunohistochemical studies
- (2010) Gulrana Khuwaja et al. BRAIN RESEARCH
- Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy
- (2010) Li Qian et al. JOURNAL OF NEURAL TRANSMISSION
- Inhibition of I B Kinase- Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity
- (2010) F. Zhang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats
- (2010) J. Guo et al. PHYTOMEDICINE
- Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1β by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells
- (2009) Y Choi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
- (2008) Hui-Ming Gao et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started